 Dronabinol
"Dronabinol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A psychoactive compound extracted from the resin of Cannabis sativa (marihuana, hashish). The isomer delta-9-tetrahydrocannabinol (THC) is considered the most active form, producing characteristic mood and perceptual changes associated with this compound.
| Descriptor ID |
D013759
|
| MeSH Number(s) |
D02.455.849.090.810
|
| Concept/Terms |
Dronabinol- Dronabinol
- delta(9)-THC
- 9-ene-Tetrahydrocannabinol
- 9 ene Tetrahydrocannabinol
- THC
- delta(1)-Tetrahydrocannabinol
- delta(1)-THC
- delta(9)-Tetrahydrocannabinol
- Tetrahydrocannabinol
|
Below are MeSH descriptors whose meaning is more general than "Dronabinol".
Below are MeSH descriptors whose meaning is more specific than "Dronabinol".
This graph shows the total number of publications written about "Dronabinol" by people in this website by year, and whether "Dronabinol" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 1 | 0 | 1 | | 2008 | 0 | 2 | 2 | | 2011 | 1 | 1 | 2 | | 2012 | 2 | 3 | 5 | | 2013 | 1 | 1 | 2 | | 2014 | 2 | 0 | 2 | | 2015 | 2 | 1 | 3 | | 2016 | 2 | 1 | 3 | | 2017 | 1 | 1 | 2 | | 2018 | 1 | 1 | 2 | | 2019 | 4 | 2 | 6 | | 2020 | 3 | 3 | 6 | | 2021 | 4 | 8 | 12 | | 2022 | 2 | 7 | 9 | | 2023 | 1 | 6 | 7 | | 2024 | 6 | 4 | 10 | | 2025 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Dronabinol" by people in Profiles.
-
Wymore EM, Wagner K, Gold C, Halmo LS. High Stakes: Exploring the Impact of Cannabis Use in Pregnancy and Lactation. Neoreviews. 2025 Apr 01; 26(4):e247-e263.
-
Kumar AR, Benson LS, Wymore EM, Phipers JE, Dempsey JC, Cort LA, Unadkat JD. Quantification and prediction of human fetal (-)-?9-tetrahydrocannabinol/(?)-11-OH-?9-tetrahydrocannabinol exposure during pregnancy to inform fetal cannabis toxicity. Nat Commun. 2025 Jan 18; 16(1):824.
-
Moore BF, Mueller NT, Perng W, Sauder KA, H?bert ET, Hoyt AT, Wymore EM, Boyle KE, Su EJ, Shapiro ALB, Kinney G, Sempio C, Klawitter J, Christians U, Dabelea D. Impact of prenatal exposure to delta 9-tetrahydrocannabinol and cannabidiol on birth size and postnatal growth trajectories. Pediatr Obes. 2025 Jan; 20(1):e13187.
-
Li T, Wang GS, Bero L, Brooks-Russell A, Tung G, Samet JM. Enhancing Methodological Approaches for Studying Health Effects of High-Concentration THC Products. Am J Public Health. 2024 Nov; 114(S8):S639-S644.
-
Bidwell LC, Martin-Willett R, Melendez SN, Rosa L, Giordano G, Hutchison KE, Bryan AD. LOTUS: Protocol for a double-blind placebo controlled randomized trial of hemp-derived cannabidiol for the treatment of cannabis use disorder. PLoS One. 2024; 19(9):e0308262.
-
Berry JL, Brooks-Russell A, Beuning CN, Limbacher SA, Lovestead TM, Jeerage KM. Cannabinoids detected in exhaled breath condensate after cannabis use. J Breath Res. 2024 Jul 23; 18(4).
-
Limbacher SA, Godbole S, Wrobel J, Wang GS, Brooks-Russell A. Dose of Product or Product Concentration: A Comparison of Change in Heart Rate by THC Concentration for Participants Using Cannabis Daily and Occasionally. Cannabis Cannabinoid Res. 2025 Feb; 10(1):53-59.
-
Henthorn TK, Wang GS, Dooley G, Brooks-Russell A, Wrobel J, Limbacher S, Kosnett M. Dose Estimation Utility in a Population Pharmacokinetic Analysis of Inhaled ?9-Tetrahydrocannabinol Cannabis Market Products in Occasional and Daily Users. Ther Drug Monit. 2024 Oct 01; 46(5):672-680.
-
Chen MY, Kramer EB, Gibson LP, Bidwell LC, Hutchison KE, Bryan AD. Investigating the Relationship Between Cannabis Expectancies and Anxiety, Depression, and Pain Responses After Acute Flower and Edible Cannabis Use. Cannabis Cannabinoid Res. 2025 Feb; 10(1):71-80.
-
Liu Y, Bainbridge J, Sillau S, Rajkovic S, Adkins M, Domen CH, Thompson JA, Seawalt T, Klawitter J, Sempio C, Chin G, Forman L, Fullard M, Hawkins T, Seeberger L, Newman H, Vu D, Leehey MA. Short-Term Cannabidiol with ?-9-Tetrahydrocannabinol in Parkinson's Disease: A Randomized Trial. Mov Disord. 2024 May; 39(5):863-875.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|